Back to Journals » OncoTargets and Therapy » Volume 17
Synergism from the Combination of Ulinastatin and Curcumin Offers Greater Inhibition against Colorectal Cancer Liver Metastases via Modulating Matrix Metalloproteinase-9 and E-Cadherin Expression [Corrigendum]
Shen F, Cai W, Li J, et al. Onco Targets Ther. 2014;7:305–314.
The authors wish to advise that Figure 2C on page 310 is incorrect. Due to an error at the time of figure assembly the images used for (b) cells treated with UTI and (c) cells treated with CUR were inadvertently duplicated. The authors apologize for this error and advise it does not affect the results of the paper.
The correct Figure 2 is shown below.
© 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.